Further data analysis and interpretation suggested the involvement of acute activation of TGFβ1, IL1β, and ADORA2A signaling, as well as the increased levels of fibrinogens and fibronectin to block coagulopathies. The gene discussed is FN1; the disease is blood coagulation disease.